🟢 1. At a Glance
Ambey Laboratories Ltd, a Delhi-based agrochemical SME, makes 2,4-D herbicides and has been around since 1985. Revenue is slowly crawling up (₹131 Cr in FY25), but profitability is meh, cash flow is negative ₹34 Cr, and working capital days have exploded. Despite this, the company is issuing ₹50 Cr worth of preferential warrants and increasing capital base to ₹37 Cr. Smells more like dilution than growth.
🎬 2. Introduction with Hook
Crop protection? ✔️
Old-school chemistry? ✔️
Debtor days doubling? ✔️
Preferential issue? Oh, hell yes.
Ambey Laboratories ticks all the SME chaos boxes. You have:
- Negative operating cash flow.
- High-interest borrowing repaid and then replaced.
- And a ₹50 Cr warrant issue, just when you were wondering where the real fertilizer was going.
Let’s dissect this lab-grown cocktail of agro formulas and financial engineering.
🌾 3. Business Model – WTF Do They Even Do?
Ambey manufactures and sells generic agrochemicals — mostly herbicides and fungicides, including:
- 🌿 2,4-D Amine Salt variants (480 to 866 gm/liter SL)
- 🧪 2,4-D Acid, 2,4-D Ester variants (ethyl, sodium, hexyl)
- 🌱 Hexaconazole (5% min) — fungicide
🚜 Customer Base: Farmers and B2B agro-distributors
🏭 Setup: In-house manufacturing with CWIP ramping up again
📦 Products: Bulk chemical ingredients; mostly off-patent
Summary? Classic old-school agro formulation player. Nothing IP-heavy, no innovation… just volume + trade margins.
💰 4. Financials Overview –
